drug resistance

You have access
Nanomedicine-based combination therapies for overcoming temozolomide resistance in glioblastomas
Chun Wang, Qiushi Li, Jian Xiao and Yang Liu

Cancer Biology & Medicine May 2023, 20 (5) 325-343; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0761
You have access
Smart drug delivery systems to overcome drug resistance in cancer immunotherapy
Wenzhe Yi, Dan Yan, Dangge Wang and Yaping Li

Cancer Biology & Medicine April 2023, 20 (4) 248-267; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0009
You have access
JaponiconeA induces apoptosis of bortezomib-sensitive and -resistant myeloma cells in vitro and in vivo by targeting IKKβ
Zilu Zhang, Chenjing Ye, Jia Liu, Wenbin Xu, Chao Wu, Qing Yu, Xiaoguang Xu, Xinyi Zeng, Huizi Jin, Yingli Wu and Hua Yan

Cancer Biology & Medicine May 2022, 19 (5) 651-668; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0473
You have access
Nanotechnology assisted photo- and sonodynamic therapy for overcoming drug resistance
Rui Li, Zhimin Chen, Zhifei Dai and Yingjie Yu

Cancer Biology & Medicine May 2021, 18 (2) 388-400; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0328
You have access
Circular RNAs: new biomarkers of chemoresistance in cancer
Jiaqi Wang, Yi Zhang, Lianyu Liu, Ting Yang and Jun Song

Cancer Biology & Medicine May 2021, 18 (2) 421-436; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0312
You have access
Evolving insights: how DNA repair pathways impact cancer evolution
Jiadong Zhou, Xiao Albert Zhou, Ning Zhang and Jiadong Wang

Cancer Biology & Medicine November 2020, 17 (4) 805-827; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0177
You have access
The crosstalk between autophagy and ferroptosis: what can we learn to target drug resistance in cancer?
Yulu Zhou, Yong Shen, Cong Chen, Xinbing Sui, Jingjing Yang, Linbo Wang and Jichun Zhou

Cancer Biology & Medicine November 2019, 16 (4) 630-646; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0158
You have access
The challenge of drug resistance in pancreatic ductal adenocarcinoma: a current overview
Francisco Quiñonero, Cristina Mesas, Kevin Doello, Laura Cabeza, Gloria Perazzoli, Cristina Jimenez-Luna, Ana Rosa Rama, Consolación Melguizo and Jose Prados

Cancer Biology & Medicine November 2019, 16 (4) 688-699; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0252
You have access
TNFa inhibitor C87 sensitizes EGFRvIII transfected glioblastoma cells to gefitinib by a concurrent blockade of TNFa signaling
Li Ma, Chunhua She, Qian Shi, Qiang Yin, Xinxin Ji, Yongrong Wang, Yulong Fan, Xinyao Kong, Peng Li, Zengfeng Sun, Xiaohui Zhang, Zhen Zhang, Jian Wang, Tong Wang, Yuanfu Xu and Wenliang Li

Cancer Biology & Medicine August 2019, 16 (3) 606-617; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0011
You have access
Identification of the Interaction between P-Glycoprotein and Anxa2 in Multidrug-resistant Human Breast Cancer Cells
Hai-chang Zhang, Fei Zhang, Bing Wu, Jing-hua Han, Wei Ji, Yan Zhou and Rui-fang Niu

Cancer Biology & Medicine June 2012, 9 (2) 99-104; DOI: https://doi.org/10.3969/j.issn.2095-3941.2012.02.003

Main menu

User menu

Search

drug resistance

Pages

Navigate

More Information

For Authors

Journal Services